Your browser doesn't support javascript.
loading
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions.
Popow, Johannes; Arnhof, Heribert; Bader, Gerd; Berger, Helmut; Ciulli, Alessio; Covini, David; Dank, Christian; Gmaschitz, Teresa; Greb, Peter; Karolyi-Özguer, Jale; Koegl, Manfred; McConnell, Darryl B; Pearson, Mark; Rieger, Maria; Rinnenthal, Joerg; Roessler, Vanessa; Schrenk, Andreas; Spina, Markus; Steurer, Steffen; Trainor, Nicole; Traxler, Elisabeth; Wieshofer, Corinna; Zoephel, Andreas; Ettmayer, Peter.
Affiliation
  • Popow J; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Arnhof H; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Bader G; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Berger H; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Ciulli A; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, James Black Centre , University of Dundee , Dow Street , DD1 5EH Dundee , Scotland, U.K.
  • Covini D; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Dank C; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Gmaschitz T; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Greb P; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Karolyi-Özguer J; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Koegl M; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • McConnell DB; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Pearson M; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Rieger M; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Rinnenthal J; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Roessler V; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Schrenk A; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Spina M; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Steurer S; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Trainor N; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, James Black Centre , University of Dundee , Dow Street , DD1 5EH Dundee , Scotland, U.K.
  • Traxler E; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Wieshofer C; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Zoephel A; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
  • Ettmayer P; Boehringer Ingelheim RCV GmbH & Co KG , 1221 Vienna , Austria.
J Med Chem ; 62(5): 2508-2520, 2019 03 14.
Article in En | MEDLINE | ID: mdl-30739444
ABSTRACT
Focal adhesion tyrosine kinase (PTK2) is often overexpressed in human hepatocellular carcinoma (HCC), and several reports have linked PTK2 depletion and/or pharmacological inhibition to reduced tumorigenicity. However, the clinical relevance of targeting PTK2 still remains to be proven. Here, we present two highly selective and functional PTK2 proteolysis-targeting chimeras utilizing von Hippel-Lindau and cereblon ligands to hijack E3 ligases for PTK2 degradation. BI-3663 (cereblon-based) degrades PTK2 with a median DC50 of 30 nM to >80% across a panel of 11 HCC cell lines. Despite effective PTK2 degradation, these compounds did not phenocopy the reported antiproliferative effects of PTK2 depletion in any of the cell lines tested. By disclosing these compounds, we hope to provide valuable tools for the study of PTK2 degradation across different biological systems.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein Kinase Inhibitors / Focal Adhesion Protein-Tyrosine Kinases / Focal Adhesion Kinase 1 Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2019 Type: Article Affiliation country: Austria

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein Kinase Inhibitors / Focal Adhesion Protein-Tyrosine Kinases / Focal Adhesion Kinase 1 Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2019 Type: Article Affiliation country: Austria